Abstract: Disclosed is a broadcast receiver. The broadcast receiver comprises a signal receiver for tuning and outputting a Q channel of a digital broadcasting signal, a demodulator for demodulating a signal of the received channel and checking a lock state M or an unlock state of a gain control signal and a timing control signal of the channel, and a demodulation controller for controlling o an operation of the demodulator and detecting a lock state of the channel based on the lock state of the gain control signal and the timing control signal.

Abstract: The invention relates to the use of INSP035 for treatment and/or prevention of fibrotic diseases, in particular of scleroderma.

Abstract: A pump including a stator, a rotor comprising an axial extension slidably and rotatably mounted at least partially in a rotor chamber of the stator, and at least first and second valves between an inlet and the rotor chamber, respectively between the rotor chamber and an outlet, that open and close as, a function of at least the angular displacement of the rotor. The pump comprises interacting cam elements on the rotor and stator and biasing elements acting on the rotor for applying a force on the rotor in the axial direction of the stator cam elements.

Abstract: A cartridge (2) with a fill level detection system (10, 10?, 10?), the cartridge comprising a substantially rigid containing wall (4) having a tubular wall portion (12) surrounding a chamber (18) for receiving liquid therein, a plunger or piston (8) mounted inside the chamber and configured to seal one side of the chamber, the plunger or piston being displaceable in the chamber towards an outlet end (14) of the cartridge, characterized in that the fill level detection system comprises a plurality of discrete fixed electrodes (24, 24?) positioned along the tubular wall portion in a juxtaposed manner in a direction of displacement D of the plunger or piston (8), and a mobile electrode member (28) fixed to the plunger or piston and displaceable therewith.

Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.

Abstract: Embodiments relate to a method and apparatus for producing polarized light, having a modulator crystal, where the modulator crystal incorporates a birefringent electro- optic material. The modulator crystal has an optic axis, a first polarization axis, and a second polarization axis, where the first polarization axis and second polarization axis are each perpendicular to the optic axis and perpendicular to each other. The apparatus can also include an electrode pair, where application of an electric field modulates light passing through the modulator crystal that is polarized along the first polarization axis. Embodiments pertain to a method and apparatus for modulating light. The apparatus incorporates a modulator crystal having an electro-optic material. The device also has at least two electrode pairs, where each electrode pair that modulates light passing through the modulator crystal that has a direction of travel that has a component parallel to the optic axis.

Abstract: A back side illumination image sensor according to an embodiment includes: a device isolation region and a pixel region that are on a front side of a first substrate; a light sensor and a readout circuit that are on the pixel region; an interlayer dielectric layer and a metal line that are on the front side of the first substrate; a second substrate that is bonded to the front side of the first substrate on which the metal line is formed; a pixel isolating dielectric layer that is on the device isolation region at a back side of the first substrate; and a microlens that is on the light sensor at the back side of the first substrate.

Abstract: Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.

Abstract: Provided is a nitride semiconductor light emitting device including: a first nitride semiconductor layer; an active layer formed above the first nitride semiconductor layer; and a delta doped second nitride semiconductor layer formed above the active layer. According to the present invention, the optical power of the nitride semiconductor light emitting device is enhanced, optical power down phenomenon is improved and reliability against ESD (electro static discharge) is enhanced.

Abstract: The subject invention provides a modular six-degrees-of-freedom spatial mechanism for spinal disc prosthesis, with up to three independent rotational and up to three independent translational degrees-of-freedom. The prosthesis can maintain non-separable, and non-restrictive, mechanical linkage by establishing a linked series, or chain, of kinematic pairs (joints) between components. In embodiment, a superior plate links to a planar pair (two independent degrees of translational freedom), which links to spherical pair (three independent degrees of rotational freedom), which links to a prismatic pair (one independent degree of translational freedom), which links to an inferior plate, completing the jointed kinematic chain. The kinematic pairs can be lower (surface contact) or higher (point, line, and/or curve contact) order pairs, or combinations.

Abstract: A method for marking an substrate, comprising coating the substrate with a white or colorless solution of a soluble alkali or alkaline earth metal salt of a weak acid and irradiating areas of the substrate to be marked such that those areas change color, wherein the substrate comprises a polysaccharide material.

Abstract: An ink formulation comprises a marking component and a metal salt that absorbs laser irradiation at 700-2000 mn and thereby causes the marking component to change colour. A copper salt in particular allows effective marking with a diode or CO2 laser.

Abstract: The invention relates to a process for the manufacturing of a protein, such as growth hormone, in mammalian cells cultured in a serum-free medium (medium free of components derived from animal serum). The medium contains cobalt and, optionally, cadmium or cyclodextrin.

Abstract: A fluorescent lamp type light emitting apparatus is provided. The light emitting apparatus comprises a cover, a light emitting module, radiation pads, and cap parts. The cover comprises a first cover and a transmissive second cover coupled to the first cover. The light emitting module comprises a plurality of light emitting diodes in the cover. The radiation pads are disposed on the light emitting module. The cap parts comprise electrode terminals at both ends of the cover.

Abstract: The present invention provides phenoxyacetic acid derivatives of Formula (I) for the treatment of CRTH2 related disorders and disease selected from asthma, atopic dermatitis and inflammatory dermatoses.

Abstract: A rotor is provided. The rotor includes a bearing yoke, a supporting member, a rotor substrate, a coil, and a weight coupled to the supporting member. The supporting member is coupled to the bearing yoke. The rotor substrate is supported by the supporting member. The coil is supported by the supporting member and electrically connected to the rotor substrate. The weight is coupled to the supporting member.

Abstract: A maternal-fetal monitoring system for use during all stages of pregnancy, including antepartum and intrapartum stages. The maternal-fetal monitoring system of the subject invention comprises (1) a set of sensors; (2) an amplifying/filtering means; (3) a computing means; and (4) a graphical user interface. Accurate clinical data, which can be extracted and provided to the user in real-time using the system of the invention, include without limitation, maternal electrocardiogram (ECG) signals, maternal uterine activity signals (EHG), maternal heart rate, fetal ECG signals, and fetal heart rate. In a preferred embodiment, the maternal-fetal monitoring system of the invention includes an intelligence means, such as a neural network system, to analyze and interpret clinical data for use in clinical diagnosis antepartum, intrapartum and postpartum, as well as delivery strategy.

Abstract: The present invention concerns a process for the purification of macrolide antibiotics. More specifically it concerns a process for the purification of macrolide antibiotics that result in a white powder. The powder remains white also after some time of storage. The process of the present invention is performed by dissolving the macrolide antibiotics, e.g. commercial vancomycin hydrochloride, in water and subjecting the solution to ultrafiltration with a membrane having nominal retention lower than 30,000 Da, preferably of 10,000 Da. The purified solution is preferably concentrated by reversed osmosis and then lyophilized at the optimized conditions of pressure and temperature to obtain a white powder.

Abstract: The invention relates to a novel molecule, termed SC5 by the inventors, to a novel allelic form of p140, and to the biological applications of SC5 and p140 molecules, notably in the diagnosis and therapy of CTCL.

Abstract: A method to compress an unoptimized Aho-Corasick automaton is provided that can be used in network intrusion detection systems. Embodiments of the subject method use bitmaps with multiple levels of summaries as well as aggressive path compaction. By using multiple levels of summaries, a popcount can be determined with as few as 1 addition.